Natasha K Martin
Biographic Data
| ID | 5573346 |
|---|---|
| NAME | Natasha K Martin |
| GIVEN NAMES | Natasha K |
| FAMILY NAME | Martin |
| SIGNATURE | MARTIN N K |
| AFFILIATIONS | University of California San Diego |
| VERIFIED | No |
| TOTAL WORKS | 20 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 20 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2013 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018–2022
Across four Montréal SIS, site visits with an overdose requiring intervention were associated with transgender identity, younger age, stable housing, intending to inject fentanyl, injecting less frequently than daily, injecting for either more than five years or less than a year, single site attendance, and injecting most often in a public place. Montréal SIS serve a diverse clientele who inject drugs, with differing risks of onsite overdose
Modeling the impact of changing drug markets and structural determinants on HCV and/or HIV transmission among people who inject drugs in the United States
Associations Between Alcohol Use, Antiretroviral Therapy Use, and Viral Load Suppression Among People Living with HIV in Rural Central Uganda
Alcohol use among people living with HIV (PWH) is common and may negatively affect engagement in HIV care. We evaluated the relationships between alcohol use, ART use, and viral suppression among PWH in Uganda. PATH/Ekkubo was a trial evaluating a linkage to HIV care intervention in four Ugandan districts, Nov 2015-Sept 2021. Our analytical sample included: (1) baseline data from individuals not enrolled in the intervention trial (previously diag…
Analyzing quality of life among people with opioid use disorder from the National Institute on Drug Abuse Data Share initiative
We observed HSUVs for OUD that were higher than those from previous studies that had been conducted without input from people living with the condition
Health-related quality of life among people who inject drugs in Australia
The study findings provide important HRQoL data for economic evaluations, useful for guiding the allocation of resources for HCV elimination strategies and interventions among PWID
Fatal overdose
Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the Covid-19 pandemic
A gender lens is needed in hepatitis C elimination research
A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the Covid-19 pandemic
This measurement framework is intended to increase the quality and timeliness of research on the impacts of COVID-19 in the context of the current pandemic and future crises. Next steps include a ranking process to narrow the drivers of change in health risks to a concise set of indicators that adequately represent framework components, can be written as measurable indicators, and are quantifiable using existing data sources, as well as a publicl…
Modelling the contribution of incarceration and public health oriented drug law reform to HCV transmission and elimination among PWID in Tijuana, Mexico
Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar
INTRODUCTION: Over half of those hepatitis C virus (HCV)/HIV coinfected live in low-income and middle-income countries, and many remain undiagnosed or untreated. In 2016, Médecins Sans Frontières (MSF) established a direct-acting antiviral (DAA) treatment programme for people HCV/HIV coinfected in Myanmar. The purpose of our study was to evaluate the real-world cost and cost-effectiveness of this programme, and potential cost-effectiveness if imp…
Overlapping Key Populations and HIV Transmission in Tijuana, Mexico
Tijuana, Mexico, has a concentrated HIV epidemic among overlapping key populations (KPs) including people who inject drugs (PWID), female sex workers (FSW), their male clients, and men who have sex with men (MSM). We developed a dynamic HIV transmission model among these KPs to determine the extent to which their unmet prevention and treatment needs is driving HIV transmission. Over 2020-2029 we estimated the proportion of new infections acquired…
Assessing HIV and overdose risks for people who use drugs exposed to compulsory drug abstinence programs (CDAP)
Is hepatitis C virus (HCV) elimination achievable among people who inject drugs in Tijuana, Mexico? A modeling analysis
The use of mathematical modeling to inform drug policy making
Responding to global stimulant use
Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs
The perfect storm
Hepatitis C virus treatment for prevention among people who inject drugs
UNLABELLED: Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs (PWID) cannot be achieved by harm reduction interventions such as needle exchange and opiate substitution therapy (OST) alone. Current HCV treatment is arduous and uptake is low, but new highly effective and tolerable interferon-free direct-acting antiviral (DAA) treatments could facilitate increased uptake. We projected the potential impact of …
No prominent works on this page.
Hepatitis C virus treatment for prevention among people who inject drugs
UNLABELLED: Substantial reductions in hepatitis C virus (HCV) prevalence among people who inject drugs (PWID) cannot be achieved by harm reduction interventions such as needle exchange and opiate substitution therapy (OST) alone. Current HCV treatment is arduous and uptake is low, but new highly effective and tolerable interferon-free direct-acting antiviral (DAA) treatments could facilitate increased uptake. We projected the potential impact of …
The perfect storm
Advancing global health and strengthening the HIV response in the era of the Sustainable Development Goals
Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs
Responding to global stimulant use
Cost and cost-effectiveness of a real-world HCV treatment program among HIV-infected individuals in Myanmar
INTRODUCTION: Over half of those hepatitis C virus (HCV)/HIV coinfected live in low-income and middle-income countries, and many remain undiagnosed or untreated. In 2016, Médecins Sans Frontières (MSF) established a direct-acting antiviral (DAA) treatment programme for people HCV/HIV coinfected in Myanmar. The purpose of our study was to evaluate the real-world cost and cost-effectiveness of this programme, and potential cost-effectiveness if imp…
Overlapping Key Populations and HIV Transmission in Tijuana, Mexico
Tijuana, Mexico, has a concentrated HIV epidemic among overlapping key populations (KPs) including people who inject drugs (PWID), female sex workers (FSW), their male clients, and men who have sex with men (MSM). We developed a dynamic HIV transmission model among these KPs to determine the extent to which their unmet prevention and treatment needs is driving HIV transmission. Over 2020-2029 we estimated the proportion of new infections acquired…
Assessing HIV and overdose risks for people who use drugs exposed to compulsory drug abstinence programs (CDAP)
Is hepatitis C virus (HCV) elimination achievable among people who inject drugs in Tijuana, Mexico? A modeling analysis
The use of mathematical modeling to inform drug policy making
Fatal overdose
Changes in supervised consumption site use and emergency interventions in Montréal, Canada in the first twelve months of the Covid-19 pandemic
A gender lens is needed in hepatitis C elimination research
A stakeholder-driven framework for measuring potential change in the health risks of people who inject drugs (PWID) during the Covid-19 pandemic
This measurement framework is intended to increase the quality and timeliness of research on the impacts of COVID-19 in the context of the current pandemic and future crises. Next steps include a ranking process to narrow the drivers of change in health risks to a concise set of indicators that adequately represent framework components, can be written as measurable indicators, and are quantifiable using existing data sources, as well as a publicl…
Modelling the contribution of incarceration and public health oriented drug law reform to HCV transmission and elimination among PWID in Tijuana, Mexico
Health-related quality of life among people who inject drugs in Australia
The study findings provide important HRQoL data for economic evaluations, useful for guiding the allocation of resources for HCV elimination strategies and interventions among PWID
Associations Between Alcohol Use, Antiretroviral Therapy Use, and Viral Load Suppression Among People Living with HIV in Rural Central Uganda
Alcohol use among people living with HIV (PWH) is common and may negatively affect engagement in HIV care. We evaluated the relationships between alcohol use, ART use, and viral suppression among PWH in Uganda. PATH/Ekkubo was a trial evaluating a linkage to HIV care intervention in four Ugandan districts, Nov 2015-Sept 2021. Our analytical sample included: (1) baseline data from individuals not enrolled in the intervention trial (previously diag…
Analyzing quality of life among people with opioid use disorder from the National Institute on Drug Abuse Data Share initiative
We observed HSUVs for OUD that were higher than those from previous studies that had been conducted without input from people living with the condition
Characteristics of supervised injection site clients and factors associated with requiring overdose intervention, Montreal, Canada, 2018–2022
Across four Montréal SIS, site visits with an overdose requiring intervention were associated with transgender identity, younger age, stable housing, intending to inject fentanyl, injecting less frequently than daily, injecting for either more than five years or less than a year, single site attendance, and injecting most often in a public place. Montréal SIS serve a diverse clientele who inject drugs, with differing risks of onsite overdose
Modeling the impact of changing drug markets and structural determinants on HCV and/or HIV transmission among people who inject drugs in the United States
Medicine (17 works) · HIV, Drug Use, Sexual Risk (16 works) · Environmental health (10 works) · Hepatitis C virus research (8 works) · HIV/AIDS Research and Interventions (8 works) · Opioid Use Disorder Treatment (7 works) · Psychiatry (7 works) · Internal Medicine (6 works) · Public health (6 works) · Virology (6 works)